NRx Pharmaceuticals

(NASDAQ) NRXP

Current Price$3.21

Market Cap$116.66M

Since IPO (2017)-97%

5 Year-99%

1 Year+20%

1 Month+8%

NRx Pharmaceuticals Financials at a Glance

Market Cap

$116.66M

Revenue (TTM)

$2.29M

Net Income (TTM)

$24.54M

EPS (TTM)

$-1.28

P/E Ratio

-2.52

Dividend

$0.00

Beta (Volatility)

0.91 (Low)

Dividend

$0.00

Beta (Volatility)

0.91 (Low)

Price

$3.21

Volume

1,484,089.832

Open

$3.08

Price

$3.21

Volume

1,484,089.832

Open

$3.08

Previous Close

$3.22

Daily Range

$3.08 - $3.36

52-Week Range

$1.62 - $3.84

Dividend

$0.00

Beta (Volatility)

0.91 (Low)

Price

$3.21

Volume

1,484,089.832

Open

$3.08

Previous Close

$3.22

Daily Range

$3.08 - $3.36

52-Week Range

$1.62 - $3.84

NRXP News

My Top 3 Biotech Stocks for May 2026

Jeff SiegelMay 20, 2026

Medical researchers - GettyImages-1096502340

Page 1

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About NRx Pharmaceuticals

Industry

Pharmaceuticals

Sector

Health Care

CEO

Jonathan C. Javitt, MD

Website

www.nrxpharma.com

Headquarters

Wilmington, DE 19801, US

NRXP Financials

Key Financial Metrics (TTM)

Gross Margin

37%

Operating Margin

-7%

Net Income Margin

-11%

Return on Equity

Return on Capital

Return on Assets

-2%

Earnings Yield

-39.68%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$116.66M

Shares Outstanding

36.23M

Volume

1.48M

Avg. Volume

973.11K

Financials (TTM)

Gross Profit

$720.00K

Operating Income

$16.22M

EBITDA

$27.81M

Operating Cash Flow

$14.11M

Capital Expenditure

$0.00

Free Cash Flow

$14.11M

Cash & ST Invst.

$7.80M

Total Debt

$631.00K

NRx Pharmaceuticals Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$1.07M

N/A

Gross Profit

$272.00K

N/A

Gross Margin

25.47%

N/A

Market Cap

$116.66M

N/A

Market Cap/Employee

$58.33M

N/A

Employees

N/A

Net Income

$1.43M

+74.1%

EBITDA

$4.58M

+16.9%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Net Cash

$5.78M

+302.8%

Accounts Receivable

$181.00K

N/A

Inventory

$0.00

N/A

Long Term Debt

$543.00K

N/A

Short Term Debt

$391.00K

-95.3%

Return on Assets

-2.06%

N/A

Return on Invested Capital

1.30%

N/A

Free Cash Flow

$4.29M

-23.4%

Operating Cash Flow

$4.29M

-23.4%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

EQEquillium, Inc.

EQEquillium, Inc.$2.26+2.26%

SPRBSpruce Biosciences, Inc.

SPRBSpruce Biosciences, Inc.$51.08-3.08%

KPTIKaryopharm Therapeutics Inc.

KPTIKaryopharm Therapeutics Inc.$8.16+1.24%

COEPCoeptis Therapeutics, Inc.

COEPCoeptis Therapeutics, Inc.$16.40+0.00%

CUECue Biopharma, Inc.

CUECue Biopharma, Inc.$21.47+6.82%

IPSCCentury Therapeutics, Inc.

IPSCCentury Therapeutics, Inc.$2.26-0.44%

SNTISenti Biosciences, Inc.

SNTISenti Biosciences, Inc.$0.99+0.28%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NOKNokia

NOKNokia$15.47+0.09%

AALAmerican Airlines Group

AALAmerican Airlines Group$13.85+0.02%

NIONio

NIONio$5.20-0.07%

INTCIntel

INTCIntel$119.84+0.01%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$15.26+0.04%

ACHRArcher Aviation

ACHRArcher Aviation$6.36+0.04%

QUBTQuantum Computing

QUBTQuantum Computing$12.31+0.08%

Questions About NRXP

What is the current price of NRx Pharmaceuticals?

NRx Pharmaceuticals is trading at $3.22 per share.

What is the 52-week range for NRx Pharmaceuticals?

Over the past 52 weeks, NRx Pharmaceuticals has traded between $1.62 and $3.84.

How much debt does NRx Pharmaceuticals have?

As of the most recent reporting period, NRx Pharmaceuticals reported total debt of $934,000.

How much cash does NRx Pharmaceuticals have on hand?

NRx Pharmaceuticals reported $6.71M in cash and cash equivalents in its most recent financial results.

What is NRx Pharmaceuticals’s dividend yield?

NRx Pharmaceuticals does not currently have a dividend yield.

NRx Pharmaceuticals

NRx Pharmaceuticals Financials at a Glance

NRXP News

My Top 3 Biotech Stocks for May 2026

Why NRx Pharmaceuticals Stock Soared Today

Why NRX Pharmaceuticals Stock Is Jumping Today

1 Small-Cap Stock With 10X Potential

Why NRx Pharmaceuticals Stock Is Tumbling Today

Why NRx Pharmaceuticals Stock Is Jumping Again on Thursday

Why NRx Pharmaceuticals Stock Is Skyrocketing Today

Why NRx Pharmaceuticals Stock Vaulted Higher Today

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About NRx Pharmaceuticals

NRXP Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

NRx Pharmaceuticals Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About NRXP

What is the current price of NRx Pharmaceuticals?

What is the 52-week range for NRx Pharmaceuticals?

How much debt does NRx Pharmaceuticals have?

How much cash does NRx Pharmaceuticals have on hand?

What is NRx Pharmaceuticals’s dividend yield?

Premium Investing Services